A Randomised Phase III Clinical Trial Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Collaborating Groups
Australasian Gastro-Intestinal Cancer Trials Group (AGITG)
Related Post
26 March, 2026
TROG welcomes new Board members and President-Elect
LATEST NEWS: 26 March 2026 We are delighted to
26 March, 2026
TROG’S 38th ASM puts focus on driving innovative trials
LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific